Correlation Between Transcode Therapeutics and Fortress Biotech

Can any of the company-specific risk be diversified away by investing in both Transcode Therapeutics and Fortress Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Transcode Therapeutics and Fortress Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Transcode Therapeutics and Fortress Biotech, you can compare the effects of market volatilities on Transcode Therapeutics and Fortress Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Transcode Therapeutics with a short position of Fortress Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Transcode Therapeutics and Fortress Biotech.

Diversification Opportunities for Transcode Therapeutics and Fortress Biotech

-0.27

Correlation Coefficient

Transcode Therapeutics  Fortress Biotech

Very good diversification

The 3 months correlation between Transcode and Fortress is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Transcode Therapeutics and Fortress Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fortress Biotech and Transcode Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Transcode Therapeutics are associated (or correlated) with Fortress Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fortress Biotech has no effect on the direction of Transcode Therapeutics i.e., Transcode Therapeutics and Fortress Biotech go up and down completely randomly.

Pair Corralation between Transcode Therapeutics and Fortress Biotech

Given the investment horizon of 90 days Transcode Therapeutics is expected to generate 2.44 times more return on investment than Fortress Biotech. However, Transcode Therapeutics is 2.44 times more volatile than Fortress Biotech. It trades about 0.11 of its potential returns per unit of risk. Fortress Biotech is currently generating about 0.05 per unit of risk. If you would invest  23.00  in Transcode Therapeutics on September 3, 2024 and sell it today you would earn a total of  12.00  from holding Transcode Therapeutics or generate 52.17% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Transcode Therapeutics  vs.  Fortress Biotech

Transcode Therapeutics

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Transcode Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Transcode Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Fortress Biotech

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Fortress Biotech are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating forward indicators, Fortress Biotech displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Transcode Therapeutics and Fortress Biotech

The main advantage of trading using opposite Transcode Therapeutics and Fortress Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Transcode Therapeutics position performs unexpectedly, Fortress Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fortress Biotech will offset losses from the drop in Fortress Biotech's long position.

The idea behind Transcode Therapeutics and Fortress Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.